đź“‹ FDA Reference

Philips Integris V5000 and BV5000

Philips Medical Systems North America

Compare similar devices

Summary: The Philips Integris V5000 and BV5000 are advanced imaging systems used primarily in interventional radiology for procedures such as embolization. These devices are utilized by radiologists and interventional cardiologists to guide and monitor minimally invasive procedures.

FDA Clearance Information

Pathway ? 510(k)
Number ? K973482 ↗
Decision Date ? November 10, 1997
Product Code ? IZI
Device Class ? Class 2
Evidence ? 419 studies

The Philips Integris V5000 and BV5000 were cleared through the FDA 510(k) pathway on November 10, 1997. Manufactured by Philips Medical Systems North America, these devices are classified as Class 2 under product code IZI.

What It Is

The Philips Integris V5000 and BV5000 are sophisticated imaging systems designed for use in interventional radiology. They provide high-resolution fluoroscopic imaging, which is essential for guiding minimally invasive procedures. These systems are equipped with advanced features that enhance image quality and enable precise visualization of vascular structures, facilitating complex interventions.

FDA-Cleared Indications

  • Use in diagnostic and interventional procedures requiring fluoroscopic and angiographic X-ray imaging.
  • Use to provide imaging guidance during procedures involving the vascular system.
  • Use during embolization procedures involving the delivery of liquid embolic agents.

Clinical Applications

  • Fluoroscopic guidance for catheter-based vascular procedures.
  • Angiographic visualization of blood vessels during interventional procedures.
  • Imaging guidance for embolization with liquid embolic agents.
  • Real-time imaging during minimally invasive procedures performed in an interventional radiology or cardiac catheterization suite.

Reported off-label uses

  • Use for image guidance during other catheter-based interventions not specifically described in the available FDA summary, when determined appropriate by the treating clinician.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • These are fixed-room X-ray fluoroscopy systems, not MRI scanners; patients and staff must follow applicable radiation-safety procedures.
  • Image quality depends on patient positioning, system settings, contrast administration, motion control and appropriate selection of imaging angles.
  • The imaging system does not determine compatibility with an embolic agent or catheter; clinicians must separately confirm that the selected devices and materials are approved and compatible.
  • Patient size, table weight limits, access to the treatment area and required C-arm or gantry positioning should be assessed before the procedure.
  • The systems require qualified operators, routine maintenance and quality-control testing; availability and performance may vary with system age and upgrades.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is the Philips Integris V5000 and BV5000 used for?

These devices are used for high-resolution imaging during interventional radiology procedures, such as embolization, to guide and monitor the delivery of treatment.

What specialties typically use this device?

Interventional radiologists and cardiologists primarily use these imaging systems in hospital settings for minimally invasive procedures.

What are the FDA-cleared indications?

These devices are indicated for use in procedures involving embolization with liquid agents, targeting vascular conditions requiring precise intervention.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you